Conjunctival Neoplasms

Phase 4 trials (2)

• mitomycin
• interferon alpha-2b

Phase 2 trials (3)

• lenalidomide
• sunitinib
• cyclophosphamide

Phase 1 trials (14)

• ranibizumab
• incomplete freund's adjuvant
• nivolumab
• multi-epitope melanoma peptide vaccine
• personalized neoantigen vaccine
• poly-iclc
• her2/neu peptide
• egfrviii peptide
• il13r alpha peptide
• epha2 peptide
• ykl-40 peptide
• agatolimod
• sargramostim
• tetanus toxoid

Organization Involved with Phase 2 Indications (2)

• National Institutes of Health (NIH)
• National Cancer Institute (NCI)

Organization Involved with Phase 1 Indications (4)

• Genentech
• University of Pittsburgh
• The New York Eye Cancer Center
• University of Virginia